BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261026
DTEND;VALUE=DATE:20261030
DTSTAMP:20260609T083754Z
CREATED:20260609T083754Z
LAST-MODIFIED:20260609T083754Z
UID:43704-1792972800-1793318399@www.pharmajournalist.com
SUMMARY:9th TPD & Induced Proximity Summit
DESCRIPTION:After a decade of innovation\, the TPD field has its first drug approval in the form of Arvinas’ Veppanu. Combined with the recovering market of 2026\, this clinical validation will unleash a new wave of innovative approaches and push TPD to a new inflection point. Already\, the headwinds are reversing with $15B worth of upfront deals involving TPD candidates and companies in 2026 alone. \nHowever\, following the risk-averse funding environment of 2025\, continued positive clinical data is key to regaining investor confidence and pharma interest. That’s why the 9th TPD & Induced Proximity Summit is returning as the globe’s definitive forum to help you gain that ever-important clinical validation. As the world’s largest and most comprehensive TPD conference featuring the latest data from early discovery to clinical development\, it is designed to help you discover the best novel targets\, optimize your degrader profile\, and accelerate your pipelines to the clinic and beyond. \nView the full event guide.
URL:http://www.pharmajournalist.com/event/9th-tpd-induced-proximity-summit/
LOCATION:The Omni Boston Hotel at the Seaport\, 450 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261026
DTEND;VALUE=DATE:20261029
DTSTAMP:20260729T154123Z
CREATED:20260729T154123Z
LAST-MODIFIED:20260729T154123Z
UID:44061-1792972800-1793231999@www.pharmajournalist.com
SUMMARY:3rd Raw Materials for Cell & Gene Therapy Summit
DESCRIPTION:Cell and gene therapies are advancing into late-stage development and commercialization\, where raw materials have become a critical determinant of whether programs succeed or fail. Small inconsistencies that once went unnoticed are now triggering regulatory scrutiny\, inflating cost of goods\, and causing delays that put timelines and patient access at risk. \nFollowing the sunshine to San Diego\, the 3rd Raw Materials for Cell & Gene Therapy Summit is the only dedicated forum designed to help you take control of this risk. Through technical case studies and cross-functional discussion\, you will uncover practical\, phase-appropriate strategies to manage variability\, strengthen supplier qualification\, and build raw material frameworks that scale confidently from early development through to commercial manufacturing. \nBy joining leading experts across quality\, MSAT\, supply chain\, and process development\, you will engage in face-to-face discussions on how peers are defining material specifications\, managing lot-to-lot variability\, and making critical qualification decisions under real development pressure. \nMove on from theory and step inside the conversations shaping how raw material strategies are implemented in practice. Across technical case studies\, peer-led discussions\, and interactive workshops\, you’ll explore how teams are managing suppliers\, qualifying materials\, overseeing supply chains\, and navigating regulatory uncertainty in real-world settings. \nExplore the 2026 Agenda to Discover: \n\n19+ cross-functional experts spanning quality\, MSAT\, and supply chain shaping raw material strategies\n2 in-depth workshops to deep dive into particulate risk and material transitions before they delay your programme\nDedicated networking sessions & interactive roundtables designed to spark meaningful\, problem-solving conversations\nFace-to-face access to peers and decision-makers to exchange practical experiences not captured in published reports\n\nView the full program here to see the 19+ speaker faculty and full session details: https://ter.li/e0a0ldog
URL:http://www.pharmajournalist.com/event/3rd-raw-materials-for-cell-gene-therapy-summit/
LOCATION:The Westgate Hotel\, 1055 2nd Ave\, San Diego\, CA\, 92101\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR